60 DEGREES PHARMACEUTICALS, INC.: cashflow_financing
| Value | {"amount": 3369752, "concept": "us-gaap:NetCashProvidedByUsedInFinancingActivities", "currency": "USD"} |
|---|---|
| Period | 2026-01-01 – 2026-03-31 |
| Status | current |
| Entity | 60 DEGREES PHARMACEUTICALS, INC. |
Provenance
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
Retrieved: 2026-08-19T18:58:51.297335+02:00
Raw response sha256:
Also addressable by official identifiers:
Cite as: FACTANKER, https://factanker.com/fact/5a7a8bc9-1353-4ba5-81b9-fa4c0eee652c
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
0001554855-26-001058Retrieved: 2026-08-19T18:58:51.297335+02:00
Raw response sha256:
f7bde1a401b286c74a2fd824ee1df541…Also addressable by official identifiers:
https://factanker.com/fact/sec/cik-0001946563/cashflow-financing/2026-03-31 (CIK, metric, reporting date)Cite as: FACTANKER, https://factanker.com/fact/5a7a8bc9-1353-4ba5-81b9-fa4c0eee652c
History
- no predecessors — first report